Archive · 5 Sep 2026
Doctors Warn Against Treating Ozempic as a Weight-Loss Shortcut
Ozempic is a prescription medicine that can help some people lose weight.
It works partly by making people feel less hungry and full for longer.
It does not directly burn fat.
Doctors say it should not be used just to lose a few kilograms without a medical check-up.
The medicine can cause problems such as nausea, diarrhea, constipation and stomach pain.
Rare but serious problems can include pancreatitis, gallstones and severe dehydration.
People with a personal or family history of medullary thyroid cancer should avoid semaglutide.
Weight can return after the medicine is stopped.
Doctors recommend using these medicines with healthy eating, physical activity and regular medical supervision.
Ozempic and other GLP-1 medicines reduce appetite, increase fullness and help regulate blood sugar.
Doctors say these prescription medicines should be used only after medical assessment and for appropriate patients.
Semaglutide is not a fat-burning drug; it lowers food intake and may reduce both fat and lean mass.
Common side effects include nausea, vomiting, diarrhea, constipation and stomach discomfort, while pancreatitis and gallbladder problems are less common risks.
Weight regain can occur after stopping treatment, making diet, exercise, monitoring and long-term planning important.
- Who
- Doctors including Chirag Tandon, Narendra BS and Sandeep Aggarwal, along with people considering GLP-1 medicines for weight loss.
- What
- The article explains how Ozempic and related medicines work, who may be eligible, their risks and why they should not be treated as lifestyle products.
- When
- As Ozempic and other GLP-1 medicines gain popularity through social media and celebrity attention.
- Where
- The article does not specify a single location; WION consulted doctors at Shardacare - Healthcity, Aster Whitefield Hospitals and Manipal Hospital Dwarka.
- Why
- To distinguish medical guidance from social-media claims and warn against unsupervised or cosmetic use.
Medically supervised treatment
Lifestyle-product use
Who should take it
Medically supervised treatment
Doctors say GLP-1 medicines can be effective for appropriately selected patients who meet medical criteria based on indicators such as BMI and metabolic conditions.
Lifestyle-product use
The article warns against using Ozempic simply to lose a few kilograms or for cosmetic purposes without a medical assessment.
Safety and risk
Medically supervised treatment
Doctors say these medicines are not inherently dangerous when patients are carefully selected, doses are increased gradually and treatment is monitored.
Lifestyle-product use
Self-medication, buying from unverified sources or accelerating doses because of social-media pressure can lead to wrong dosing and avoidable risks.
Duration and expectations
Medically supervised treatment
For qualifying patients, GLP-1 medicines may be part of prolonged weight management alongside healthy eating and exercise.
Lifestyle-product use
The belief that a short course will permanently solve weight problems is misleading because weight regain can occur after treatment stops.
- Active ingredient
- Ozempic contains semaglutide, a GLP-1 receptor agonist.
- How it works
- It can suppress appetite, increase satiety, delay stomach emptying and regulate blood sugar.
- Reported average weight loss
- Clinical use cited by one doctor showed average weight loss of around 15% of total body weight, though results vary.
- Common side effects
- Nausea, vomiting, diarrhea, constipation, stomach discomfort and reduced appetite.
- Serious concerns
- Possible complications include pancreatitis, gallstones, gallbladder inflammation and severe dehydration.
- Important contraindication
- People with a personal or family history of medullary thyroid carcinoma should avoid semaglutide; MEN2 patients require particular attention.
- Treatment approach
- Doctors recommend proper patient selection, gradual dose increases, monitoring, dietary changes and physical activity.